Search Market Research Report
Skin and Wound Disinfection Market Size, Share Global Analysis Report, 2021 – 2026
Skin and Wound Disinfection Market By Wound Type (Acute Wound, Chronic Wound, and Surgical Wound), By Treatment (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactive, And Others), By End-User (Hospitals & Specialty Clinics, Home Healthcare, Outpatient Settings, and Others), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026
Industry Insights
[195+ Pages Report] Facts & Factors published global skin and wound disinfection market report encompasses the entire market history and forecast. In this study, the global skin and wound disinfection market witnessed a value of USD 21 Billion by 2020, and with growth at a CAGR of 4% is expected to reach a value of USD 26 Billion by 2026.
Market Overview
Skin and wound disinfection is a process wherein the wounded area is treated using various medical products and procedures in order to kill the harmful microorganisms. Some of the disinfection products used include cetrimide, chlorhexidine, etc. As leaving a wounded area untreated could cause serious health issues, it is important to use sterile products or solutions.
Industry Growth Factors
The primary factor bolstering the market growth is the rising prevalence of skin and wound infections, the growing geriatric population, and high incidences of diabetes across the globe. Growing developments in R&D coupled with the launch of advanced products will further promote the demand for skin and wound disinfection products. The increase in a number of wounded patients and favoring reimbursement policies fuel the market expansion over the forecast period.
The launch of acellular dermal matrix named DERMGEN by Lake Superior Center for Regenerative Medicine (Renamed) will further help drive the global skin and wound disinfection market. Furthermore, the popularity of negative pressure wound therapy helps advance skin and wound disinfection products across the globe. The rising adoption of new products among healthcare providers and patients will further bolster the global skin and wound disinfection market. However, the skin and wound disinfection market is likely to face a negative impact due to the current COVID-19 pandemic as the patients are avoiding wound management in hospitals or clinics due to the fear of contracting the disease.
The outbreak of the new strain of COVID-19 is likely to further affect the market growth during the forecast period. Even the delay in the diagnosis of the wounds such as foot ulcers and lack of awareness regarding hard-to-heal wounds, absence of standard guidelines, high cost of advanced products, and limited accessibility to developed healthcare facilities are other factors likely to restrain the global skin and wound disinfection market.
Segmentation Analysis
The global skin and wound disinfection market is segmented based on wound type, treatment, end-user, application, and regions.
Based on the wound type, the global skin and wound disinfection market is categorized into the acute wound, chronic wounds, and surgical wounds. The chronic wound segment is anticipated to dominate the global skin and wound disinfection market due to the increasing number of patients suffering from diabetic foot ulcers and the high cost of the treatment of these kinds of wounds. On the basis of treatment, the market is categorized into advanced wound dressing, traditional wound care products, negative pressure wound therapy, bioactive, and others.
The advanced wound dressings segment is anticipated to dominate the market. The dominance is primarily due to the rising number of road accidents. Furthermore, the next generation of innovative wound dressing kits is likely to profit the market. By end-user, the skin and wound disinfection market is classified into hospitals & specialty clinics, home healthcare, outpatient settings, and others. From all these, the hospital & specialty clinic segment holds the largest market share as the development in the hospital infrastructure is taking place at a rapid pace. Furthermore, the rising healthcare expenditure, favorable reimbursement policies, and improved patient care in hospitals will further bolster industry growth.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 21 Billion |
Projected Market Size in 2026 |
USD 26 Billion |
CAGR Growth Rate |
4% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
Alliqua Biomedical, Inc., Smith & Nephew plc., Leap Therapeutics, Inc., 3M Company, Mölnlycke Health Care AB, Bsn Medical GmbH, and Others |
Key Segment |
By Wound Type, By Treatment, By End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
North America accounts for the largest market value. The growing skincare related product concerns and technological developments are factors anticipated to boost the skin and wound care market over the forecast period.
Competitive Players
Some of the key players participating in the skin and wound disinfection market include
- Alliqua Biomedical Inc.
- Smith & Nephew plc.
- Leap Therapeutics Inc.
- 3M Company
- Mölnlycke Health Care AB
- Bsn Medical GmbH
- Covidien plc.
- Coloplast A/S
- Derma Sciences Inc.
- Hollister Incorporated
- ConvaTec Group plc.
- Baxter International Inc.
- Deroyal Industries Inc.
- Ethicon
- Novabay Pharmaceuticals Inc.
- Hematris Wound Care GmbH
- Acelity L.P. Inc.
- Triage Meditech Pvt. Ltd
By Wound Type Segment Analysis
- Acute Wound
- Chronic Wound
- Surgical Wound
By Treatment Segment Analysis
- Advanced Wound Dressing
- Antimicrobial dressing
- Alginate dressing
- Hydrogel dressings
- Foam dressings
- Film dressings
- Hydrocolloidal dressings
- Others
- Traditional Wound Care Products
- Negative Pressure Wound Therapy
- Bioactive
- Growth Factors
- Biological Skin Equivalents
- Others
- Others
By End-User Segment Analysis
- Hospitals & Specialty Clinics
- Home Healthcare
- Outpatient Settings
- Others
By Regional Segment Analysis
- North America
- U.S.
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Table of Content
Industry Major Market Players
- Alliqua Biomedical Inc.
- Smith & Nephew plc.
- Leap Therapeutics Inc.
- 3M Company
- Mölnlycke Health Care AB
- Bsn Medical GmbH
- Covidien plc.
- Coloplast A/S
- Derma Sciences Inc.
- Hollister Incorporated
- ConvaTec Group plc.
- Baxter International Inc.
- Deroyal Industries Inc.
- Ethicon
- Novabay Pharmaceuticals Inc.
- Hematris Wound Care GmbH
- Acelity L.P. Inc.
- Triage Meditech Pvt. Ltd
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors